Does reimbursement influence chemotherapy treatment for cancer patients?

Health Affairs
Mireille JacobsonJoseph P Newhouse

Abstract

Before the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003, Medicare reimbursed physicians for chemotherapy drugs at rates that greatly exceeded physicians' costs for those drugs. We examined the effect of physician reimbursement on chemotherapy treatment of Medicare beneficiaries older than age sixty-five with metastatic lung, breast, colorectal, or other gastrointestinal cancers between 1995 and 1998 (9,357 patients). A physician's decision to administer chemotherapy to metastatic cancer patients was not measurably affected by higher reimbursement. Providers who were more generously reimbursed, however, prescribed more-costly chemotherapy regimens to metastatic breast, colorectal, and lung cancer patients.

References

Feb 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C H KöhneH J Schmoll
Mar 29, 2000·CA: a Cancer Journal for Clinicians·R T GreenleeP A Wingo
Aug 21, 2002·Medical Care·Craig C EarleJoan L Warren

❮ Previous
Next ❯

Citations

Mar 18, 2010·JAMA : the Journal of the American Medical Association·Elena B Elkin, Peter B Bach
Apr 19, 2012·JAMA : the Journal of the American Medical Association·Junya ZhuDeborah Schrag
Jun 12, 2008·JAMA : the Journal of the American Medical Association·Sarah Elizabeth Harrington, Thomas J Smith
Nov 6, 2012·International Journal of Health Care Finance and Economics·Andrew J Epstein, Scott J Johnson
Sep 27, 2013·International Journal of Health Care Finance and Economics·Makoto Kakinaka, Ryuta Ray Kato
Oct 1, 2013·Annales pharmaceutiques françaises·J C Robinson
Jun 6, 2006·The Lancet Oncology·David H Johnson
Oct 20, 2012·Health Economics, Policy, and Law·Corinna Sorenson
Jan 30, 2009·The New England Journal of Medicine·Peter B Bach
May 27, 2011·The New England Journal of Medicine·Thomas J Smith, Bruce E Hillner
Feb 21, 2007·Disease Management : DM·Donald E Fetterolf, Rachel Terry
Oct 23, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H Roché, L T Vahdat
Dec 7, 2010·Journal of the National Cancer Institute·Sean P ElliottBeth A Virnig
Dec 20, 2011·Journal of the National Cancer Institute·Jona A HattangadiRinaa S Punglia
Jul 13, 2012·Ophthalmic Plastic and Reconstructive Surgery·Sulene L ChiFrank A Sloan
Aug 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Craig C EarleJohn Z Ayanian
Jan 9, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Aileen B ChenDeborah Schrag
Sep 3, 2011·Journal of Oncology Practice·Lee N Newcomer
Nov 28, 2012·Journal of Oncology Practice·Christine B WeldonJulian C Schink
Sep 4, 2012·Journal of Oncology Practice·Carrie H CollaEllen Meara
Sep 4, 2012·Journal of Oncology Practice·Rena M ContiYa-Chen Tina Shih
Feb 15, 2014·International Health·Jing Hua ZhangHsien-Ming Lien
Dec 18, 2013·Expert Review of Pharmacoeconomics & Outcomes Research·Julieta F Scalo, Karen L Rascati
Oct 6, 2012·Mayo Clinic Proceedings·Mustaqeem Siddiqui, S Vincent Rajkumar
Nov 3, 2009·Health Services Research·Dana P GoldmanEric Sun
Dec 17, 2014·Journal of Pain and Symptom Management·Melissa M GarridoHolly G Prigerson
Oct 2, 2015·Journal of the National Cancer Institute·Matthew KoshyDavid J Sher
Oct 29, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Laure BenjaminGwenaëlle Vidal-Trécan
Sep 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joshua McFarlaneThomas J Smith
Nov 5, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lowell E Schnipper, Neal J Meropol
Jan 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter B Bach
Jan 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Scott D Ramsey
Jan 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Neal J Meropol, Kevin A Schulman
Jan 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Deborah Schrag, Morgan Hanger
Mar 10, 2016·Journal of Oncology Practice·Shellie D EllisMorris Weinberger
Jan 8, 2015·Journal of Oncology Practice·Amy J DavidoffSteven D Gore
Jun 11, 2015·Journal of Oncology Practice·Stacie B DusetzinaNancy L Keating
May 21, 2015·Journal of Oncology Practice·Manali I PatelArnold Milstein

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.